CMA
ABBV icon

Cedar Mountain Advisors’s AbbVie ABBV Stock Holding History

Cedar Mountain Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
630
+243
+63% +$52.3K 0.03% 83
2026
Q1 		$84.1K Buy
387
+68
+21% +$15.1K 0.02% 106
2025
Q4 		$72.9K Buy
319
+2
+0.6% +$456 0.01% 96
2025
Q3 		$73.4K Buy
317
+72
+29% +$14.7K 0.01% 93
2025
Q2 		$45.5K Buy
245
+2
+0.8% +$372 0.01% 105
2025
Q1 		$50.9K Buy
243
+2
+0.8% +$389 0.01% 93
2024
Q4 		$42.8K Buy
241
+2
+0.8% +$368 0.01% 99
2024
Q3 		$47.1K Buy
239
+2
+0.8% +$373 0.01% 86
2024
Q2 		$40.7K Sell
237
-9
-4% -$1.49K 0.01% 85
2024
Q1 		$44.8K Buy
246
+2
+0.8% +$345 0.01% 78
2023
Q4 		$37.8K Buy
244
+13
+6% +$1.9K 0.01% 86
2023
Q3 		$34.4K Buy
231
+2
+0.9% +$294 0.01% 86
2023
Q2 		$30.8K Buy
229
+22
+11% +$3.23K 0.01% 95
2023
Q1 		$32.9K Sell
207
-78
-27% -$11.9K 0.01% 90
2022
Q4 		$46K Buy
285
+2
+0.7% +$307 0.01% 75
2022
Q3 		$38K Buy
283
+2
+0.7% +$287 0.01% 80
2022
Q2 		$43K Buy
281
+2
+0.7% +$306 0.01% 78
2022
Q1 		$45K Buy
279
+2
+0.7% +$291 0.01% 81
2021
Q4 		$38K Buy
277
+2
+0.7% +$236 0.01% 89
2021
Q3 		$30K Buy
275
+82
+42% +$9.37K 0.01% 98
2021
Q2 		$22K Buy
193
+2
+1% +$225 0.01% 109
2021
Q1 		$21K Buy
191
+3
+2% +$321 0.01% 126
2020
Q4 		$20K Buy
188
+2
+1% +$192 0.01% 120
2020
Q3 		$16K Buy
186
+2
+1% +$188 0.01% 117
2020
Q2 		$18K Buy
184
+2
+1% +$176 0.01% 105
2020
Q1 		$14K Buy
182
+3
+2% +$256 0.01% 102
2019
Q4 		$16K Buy
+179
New +$14.9K 0.01% 118

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cedar Mountain Advisors's ABBV Position: Q2 2026 in Review

Cedar Mountain Advisors increased its AbbVie (ABBV) stake by 63% in Q2 2026, buying an estimated $52.3K and bringing the position to 630 shares worth $159K. The position accounts for 0.03% of the portfolio, ranked #83.

Cedar Mountain Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cedar Mountain Advisors held 630 shares of AbbVie worth $159K as of Q2 2026.
  • Cedar Mountain Advisors bought 243 AbbVie shares in Q2 2026, an estimated $52.3K.
  • AbbVie made up 0.03% of Cedar Mountain Advisors's portfolio in Q2 2026, its #83 holding.
  • Cedar Mountain Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.